HEYL and COVID-19: To our knowledge, our work may present a novel approach in interpretation of the severity of COVID-19 in aging patients and it is the first time to compare the methylation status of HeyL promoter in Egyptian population in either COVID-19 patients or healthy subjects with that published in GenBank HeyL.